Abstract
The structure-activity relationships of N-terminal modified RGD peptides against platelet aggregation inhibitory activity were studied, and Orotyl-Ser-Arg-Gly-Asp-Trp (NSL-9403) was found to be a new and effective anti-thrombotic agent during extracorporeal circulation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have